Fertility Supplement Market Report 2026

The fertility supplement market size has grown strongly in recent years. It will grow from $1.93 billion in 2025 to $2.09 billion in 2026 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to increased awareness of reproductive nutrition, growth in dietary supplement consumption, expansion of health retail stores, rising infertility concerns, availability of otc fertility supplements.

The fertility supplement market size is expected to see strong growth in the next few years. It will grow to $2.8 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to innovation in fertility-focused formulations, growth in preventive reproductive health, increasing use of personalized supplements, expansion of digital health platforms, rising consumer trust in nutraceuticals. Major trends in the forecast period include rising use of nutritional supplements for fertility support, growing preference for natural and herbal ingredients, increased demand from both male and female consumers, expansion of over-the-counter fertility products, growth of online supplement sales channels.

The growing prevalence of infertility is expected to drive the expansion of the fertility supplement market in the coming years. Infertility is defined as the inability to achieve pregnancy after one year of regular, unprotected intercourse or the inability to sustain a pregnancy to full term. The rise in infertility rates is attributed to factors such as delayed parenthood, lifestyle modifications, exposure to environmental toxins, increasing obesity levels, and heightened stress. Fertility supplements play an important role in addressing infertility by supplying essential vitamins, minerals, and nutrients that support reproductive health, hormonal balance, and overall fertility function. For example, in April 2023, the World Health Organization (WHO), a Switzerland-based United Nations specialized agency for global public health, reported that approximately 17.5% of the global adult population - about one in six people - experience infertility. Therefore, the rising prevalence of infertility is driving the growth of the fertility supplement market.

Leading companies in the fertility supplement market are concentrating on the development of personalized offerings, such as natural fertility supplements, to provide a holistic approach to improving reproductive health through plant-based ingredients and essential nutrients, while minimizing synthetic chemicals and potential side effects associated with conventional therapies. Natural fertility supplements are dietary products formulated with plant-derived ingredients, vitamins, and minerals that aim to enhance fertility by supporting hormonal regulation, egg quality, and overall reproductive performance. For instance, in November 2024, Nestlé, a Switzerland-based health and wellness company, introduced Materna Pre and Materna Nausea solutions. The Materna portfolio was expanded with two new products designed to support women’s fertility and help manage common pregnancy-related symptoms, including nausea and vomiting. The Materna Nausea product incorporates natural ginger and vitamin B6 and is scientifically proven to reduce the severity of nausea and vomiting during pregnancy. This launch underscores Materna’s commitment to delivering customized, science-backed nutritional solutions that support women before conception, throughout pregnancy, and after childbirth, with the goal of improving health outcomes for both mothers and infants.

In March 2023, Sumitovant Biopharma Ltd., a US-based pharmaceutical company, acquired Myovant Sciences Ltd. for $1.7 billion. Through this acquisition, Sumitomo Pharma aims to leverage the combined capabilities of Sumitovant and Myovant to accelerate the development of innovative therapies. The integration is intended to maximize the potential of products such as ORGOVYX and MYFEMBREE, expand the availability of differentiated treatment options, and advance ongoing clinical programs. Myovant Sciences Ltd. is a UK-based company focused on the development of fertility supplements.

Major companies operating in the fertility supplement market are GNC Holdings LLC, Orthomol Holding, Vitabiotics Ltd., Lenus Pharma GesmbH, Innovamed Ltd., AdvaCare Pharma, Theralogix LLC, Fairhaven Health LLC, Coast Science LLC, Bionova Inc., Extreme V Inc., Crown Fertility, Xena Bio Herbals Pvt. Ltd., Zenith Nutrition Co, Amitamin, Eu Natural Inc., Proxeed, Babystart Ltd., Needed Inc., Ritual, Premama Wellness Company, Pink Stork.

North America was the largest region in the fertility supplement market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fertility supplement market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the fertility supplement market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have raised costs in the fertility supplement market by increasing prices for imported vitamins, herbal extracts, capsules, and packaging materials. Supplement manufacturers and pharmacies in Asia-Pacific and emerging regions are most affected due to global ingredient sourcing. These higher costs can increase retail prices for consumers. However, tariffs are encouraging domestic sourcing and supplement production, improving long-term supply stability.

The fertility supplement market research report is one of a series of new reports that provides fertility supplement market statistics, including fertility supplement industry global market size, regional shares, competitors with a fertility supplement market share, detailed fertility supplement market segments, market trends and opportunities, and any further data you may need to thrive in the fertility supplement industry. This fertility supplement market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Fertility supplements are dietary products formulated to support reproductive health and enhance fertility. They typically contain a combination of vitamins, minerals, herbs, and other natural compounds that help promote hormonal balance, improve egg quality, support sperm health, and enhance overall reproductive function. These supplements are widely used by individuals seeking to conceive or address fertility-related concerns.

The main product forms of fertility supplements include tablets, capsules, powders, liquids, soft gels, and others. Tablets are solid, compressed forms that allow for convenient dosing and are commonly used. These supplements are made from natural ingredients, synthetic ingredients, or a combination of both, and are distributed through various channels such as over-the-counter outlets, prescription-based sales, and others. They are intended for use by both men and women.

The fertility supplement market consists of sales of prenatal vitamins, ovulation support supplements, PCOS treatment supplements, and sperm health supplements. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.